Orodispersible Tablets Market Size is valued at 10.71 billion in 2024 and is predicted to reach 29.47 billion by the year 2034 at a 10.8% CAGR during the forecast period for 2025-2034.
The orodispersible tablets market, known as orally disintegrating tablets (ODTs), has acquired substantial interest and appeal in the pharmaceutical sector. These tablets are designed to dissolve fast in the mouth without needing water or swallowing, making them an appealing option for patients who struggle to swallow regular tablets or capsules. Because it includes mostly medical compounds in solid dosage form, orodispersible pills break down quickly, usually in seconds, when placed on the tongue. Because it directly solves pharmaceutical and patient demands, this novel ODT technology improves the patient life cycle.
It creates a comfortable dosage strategy for pediatric, geriatric, and psychiatric patients with dysphagia. This new technology motivates the academic industry to produce a newer orally disintegrating formulation and technology, as well as an evaluation approach suited for drug candidates in the future.
However, Creating an orodispersible tablet formulation with adequate flavor, stability, and disintegration qualities can be difficult. The formulation must protect the tablet during manufacture, packaging, and storage while allowing rapid breakdown in the oral cavity.
The Orodispersible Tablets market is segmented based on drug class, disease indication, distribution channel, age group, and technology. The market is divided into analgesics, antiemetics, antipsychotics, anti-inflammatory drugs, sedatives/hypnotics, and antihypertensives. Based on the disease indication is divided into disorders, respiratory disorders, allergies and asthma, among others.
The market is segmented by distribution channel into hospital pharmacies, retail pharmacies, and online pharmacies. Furthermore, it is divided based on age groups into pediatric, adult, and geriatric patients. End users, including hospitals, clinics, ambulatory surgical centers, and home care settings, also categorize the market. Additionally, the market is segmented by technology into lyophilization, tablet molding, spray drying, sublimation, and other methods.
The anti-inflammatory category will hold a major share of the global Orodispersible Tablets market 2022. Increasing research spending in biologics for treating autoimmune inflammatory illnesses has resulted in potential pipeline medications. The benefits of monoclonal antibodies' anti-inflammatory characteristics have turned the emphasis of pharmaceutical behemoths to this field. The firms are developing anti-tumor necrosis factor (TNF) inhibitors, interleukins, and other agents to treat various inflammatory illnesses.
The respiratory disorders segment is projected to grow rapidly in the global Orodispersible Tablets market. The concentration of medicines taken orally is significantly reduced medication before it enters the bloodstream, and here is where the ability of Orally Disintegrating Tablets to prevent first-pass metabolism helps solve such problems. Orally disintegrating tablets with higher bioavailability for protein and peptide-based therapies are a feasible option for delivering high molecular weight medicines, and this aspect is expected to drive the Orally Disintegrating Tablet Market growth in the coming years.
The North American market for orodispersible tablets is expected to hold the largest market share in revenue shortly. The region is experiencing growth primarily because of the established presence of pharmaceutical companies, a strong healthcare infrastructure, and substantial healthcare spending. An increasing prevalence of chronic diseases, a growing elderly population, and a heightened focus on patient-centered treatments also drive the region. Technological advancements, robust regulatory frameworks, and high awareness among healthcare professionals and patients fuel the region's market growth.
However, the Asia Pacific region is projected to exhibit rapid growth in the global market for orodispersible tablets. This growth is driven by the region's large population, escalating healthcare costs, and increasing awareness of innovative medication delivery technologies. Rapidly emerging economies like China and India are witnessing a rise in chronic diseases and a demand for user-friendly drug administration methods, creating opportunities for the orodispersible tablets market.
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 10.71 Bn |
|
Revenue Forecast In 2031 |
USD 29.47 Bn |
|
Growth Rate CAGR |
CAGR of 10.8% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Mn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
Drug Class, Disease Indication, Distribution Channel, Age Group, And Technology |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; South Korea; South East Asia |
|
Competitive Landscape |
AstraZeneca PLC, GlaxoSmithKline PLC, Novartis International AG, Johnson & Johnson Services, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Pfizer Inc, Cipla Limited, Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Ltd, Lupin Pharmaceuticals, Inc, Torrent Pharmaceuticals Ltd, F. Hoffmann-La Roche Ltd, Eisai Co., Ltd, Takeda Pharmaceutical Company Limited. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Orodispersible Tablets Market Snapshot
Chapter 4. Global Orodispersible Tablets Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Metaverse Industry
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact on Metaverse Industry
Chapter 5. Market Segmentation 1: By Drug Class Estimates & Trend Analysis
5.1. By Drug Class & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Drug Class:
5.2.1. Analgesics
5.2.2. Antiemetics
5.2.3. Antipsychotics
5.2.4. Anti-inflammatory Drugs
5.2.5. Sedatives/Hypnotics
5.2.6. Antihypertensives
5.2.7. Others
Chapter 6. Market Segmentation 2: By Disease Indication Estimates & Trend Analysis
6.1. By Drug Class & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Disease Indication:
6.2.1. Central Nervous System Disorders
6.2.2. Gastrointestinal Disorders
6.2.3. Cardiovascular Disorders
6.2.4. Respiratory Disorders
6.2.5. Allergy and Asthma
6.2.6. Others
Chapter 7. Market Segmentation 3: By Distribution Channel Estimates & Trend Analysis
7.1. By Drug Class & Market Share, 2024-2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Distribution Channel:
7.2.1. Hospital Pharmacies
7.2.2. Retail Pharmacies
7.2.3. Online Pharmacies
Chapter 8. Market Segmentation 4: By Age Group Estimates & Trend Analysis
8.1. By Drug Class & Market Share, 2024-2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Age Group:
8.2.1. Pediatric Patients
8.2.2. Adult Patients
8.2.3. Geriatric Patients
Chapter 9. Market Segmentation 5: By End-User Estimates & Trend Analysis
9.1. By Drug Class & Market Share, 2024-2034
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-User :
9.2.1. Hospitals
9.2.2. Clinics
9.2.3. Ambulatory Surgical Centers
9.2.4. Homecare Settings
Chapter 10. Market Segmentation 6: By Technology Range Estimates & Trend Analysis
10.1. By Age Group & Market Share, 2024-2034
10.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Technology Range:
10.2.1. Lyophilization
10.2.2. Tablet Molding
10.2.3. Spray Drying
10.2.4. Sublimation
10.2.5. Others
Chapter 11. Orodispersible Tablets Market Segmentation 10: Regional Estimates & Trend Analysis
11.1. North America
11.1.1. North America Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Drug Class, 2021-2034
11.1.2. North America Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2021-2034
11.1.3. North America Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Distribution Channel , 2021-2034
11.1.4. North America Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Age Group, 2021-2034
11.1.5. North America Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By End-User , 2021-2034
11.1.6. North America Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Technology Range, 2021-2034
11.1.7. North America Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
11.1.7.1. U.S.
11.1.7.2. Canada
11.2. Europe
11.2.1. Europe Orodispersible Tablets Market revenue (US$ Million) by By Drug Class, 2021-2034
11.2.2. Europe Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2021-2034
11.2.3. Europe Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Distribution Channel , 2021-2034
11.2.4. Europe Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Age Group, 2021-2034
11.2.5. Europe Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By End-User , 2021-2034
11.2.6. Europe Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Technology Range, 2021-2034
11.2.7. Europe Orodispersible Tablets Market revenue (US$ Million) by country, 2021-2034
11.2.7.1. Germany
11.2.7.2. Poland
11.2.7.3. France
11.2.7.4. Italy
11.2.7.5. Spain
11.2.7.6. UK
11.2.7.7. Rest of Europe
11.3. Asia Pacific
11.3.1. Asia Pacific Orodispersible Tablets Market revenue (US$ Million) by By Drug Class, 2021-2034
11.3.2. Asia Pacific Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Age Group, 2021-2034
11.3.3. Asia Pacific Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2021-2034
11.3.4. Asia Pacific Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Distribution Channel , 2021-2034
11.3.5. Asia Pacific Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Age Group, 2021-2034
11.3.6. Asia Pacific Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By End-User , 2021-2034
11.3.7. Asia Pacific Orodispersible Tablets Market revenue (US$ Million) by country, 2021-2034
11.3.7.1. China
11.3.7.2. India
11.3.7.3. Japan
11.3.7.4. Australia
11.3.7.5. Rest of Asia Pacific
11.4. Latin America
11.4.1. Latin America Orodispersible Tablets Market revenue (US$ Million) by By Drug Class, 2021-2034
11.4.2. Latin America Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Age Group, 2021-2034
11.4.3. Latin America Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2021-2034
11.4.4. Latin America Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Distribution Channel , 2021-2034
11.4.5. Latin America Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Age Group, 2021-2034
11.4.6. Latin America Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By End-User , 2021-2034
11.4.7. Latin America Orodispersible Tablets Market revenue (US$ Million) by country, (US$ Million) 2021-2034
11.4.7.1. Brazil
11.4.7.2. Rest of Latin America
11.5. Middle East & Africa
11.5.1. Middle East & Africa Orodispersible Tablets Market revenue (US$ Million) by By Drug Class, (US$ Million)
11.5.2. Middle East & Africa Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Age Group, 2021-2034
11.5.3. Middle East & Africa Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2021-2034
11.5.4. Middle East & Africa Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Distribution Channel , 2021-2034
11.5.5. Middle East & Africa Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By Age Group, 2021-2034
11.5.6. Middle East & Africa Orodispersible Tablets Market revenue (US$ Million) estimates and forecasts By End-User , 2021-2034
11.5.7. Middle East & Africa Orodispersible Tablets Market revenue (US$ Million) by country, (US$ Million) 2021-2034
11.5.7.1. South Africa
11.5.7.2. GCC Countries
11.5.7.3. Rest of MEA
Chapter 12. Competitive Landscape
12.1. Major Mergers and Acquisitions/Strategic Alliances
12.2. Company Profiles
12.2.1. AstraZeneca PLC,
12.2.2. GlaxoSmithKline PLC,
12.2.3. Novartis International AG,
12.2.4. Johnson & Johnson Services, Inc.,
12.2.5. Teva Pharmaceutical Industries Ltd.,
12.2.6. Merck & Co., Inc.,
12.2.7. Pfizer Inc.,
12.2.8. Cipla Limited,
12.2.9. Dr. Reddy's Laboratories Ltd.,
12.2.10. Sun Pharmaceutical Industries Ltd.,
12.2.11. Lupin Pharmaceuticals, Inc.,
12.2.12. Torrent Pharmaceuticals Ltd.,
12.2.13. F. Hoffmann-La Roche Ltd.,
12.2.14. Eisai Co., Ltd.,
12.2.15. Takeda Pharmaceutical Company Limited.
By Drug Class-
By Disease Indication -
By Distribution Channel -
By Age Group -
By End User -
By Technology -
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
